On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.
More Latest News
July 10, 2019
Click here for new profession requirements and reporting procedures regarding Human Trafficking Continue reading
July 8, 2019
Click here to view the Board of Medicine’s emergency rule that clarifies the standard of care for gluteal fat grafting. Continue reading